- About ABC
- COVID-19 and the Brain
- Contact Us
As the largest coalition advocating for brain science, the ABC established the Innovation Initiative (ABCI2), a collaborative program to stimulate private investment in brain-related research and strengthen the entire research and development system for expedited translation of neuroscience research into life changing therapies and cures. This ABC advocacy effort is comprised of key stakeholders within the brain community, including patient advocacy groups, professional societies, and industry, collaborating to advance policy positions, legislation and regulations that will strengthen for-profit incentives to invest in neuroscience research.
The goals and objectives of the American Brain Coalition Innovation Initiative (ABCI2) are to:
The ABC will lead the community in identifying the causes for divestment, building the case for why reinvestment is important to patients and the public, identifying educational, legislative and/or regulatory solutions, and advocating for those solutions.
Leveraging the existing infrastructure, the ABC has expanded its focus to generate and disseminate a higher volume and quality of information related to the need for private investment in neuroscience research. This focused effort will amplify existing elements of our successful, multi-dimensional issue-advocacy campaign.
“The ABC is grateful to our industry partners
and clinical neuroscience research;
we desire to see their work continue
and grow for many years to come.”
Robin Elliott, ABCI2 Chair